Clincosm LogoSign in Get a demo

cancer

Showing NaN - NaN of 97
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Physical Inactivity, Overweight or Obesity, Cancer Trial in Los Angeles (Intensity-Based Goals, Affect-Based Goals, TYPE/CONTEXT

Recruiting
  • Physical Inactivity
  • +2 more
  • Intensity-Based Goals
  • +3 more
  • Los Angeles, California
    University of Southern California
Nov 7, 2023

Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +19 more
  • A2B694
  • xT CDx with HLA-LOH Assay
  • Duarte, California
  • +9 more
Sep 22, 2023

Health Maintenance, Diabetes, Cancer Trial in Los Angeles (Reminder of preventive care measures, Persuasion via anecdote,

Enrolling by invitation
  • Health Maintenance
  • +2 more
  • Reminder of preventive care measures
  • +3 more
  • Los Angeles, California
    UCLA Health Department of Medicine, Quality Office
Jul 30, 2023

Implementation ofPharmacist-Based, Post-Chemotherapy Follow-up

Recruiting
  • Cancer
  • Follow-up phone interview
  • Los Angeles, California
    Cedars-Sinai Medical Center
Jul 20, 2023

Serial PET MPI in Patients Undergoing Cancer Treatment

Enrolling by invitation
  • Cancer
  • +3 more
    • Los Angeles, California
      West Los Angeles VA Medical Center
    Jun 12, 2023

    Health Maintenance, Diabetes, Cancer Trial in Los Angeles (Outreach Text Messages, Specific, General)

    Enrolling by invitation
    • Health Maintenance
    • +2 more
    • Outreach Text Messages
    • +4 more
    • Los Angeles, California
      UCLA Health Department of Medicine, Quality Office
    Mar 30, 2023

    Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

    Not yet recruiting
    • Solid Tumor, Adult
    • +15 more
    • A2B530
    • xT-Onco with HLA-LOH Assay
    • Duarte, California
    • +6 more
    Feb 10, 2023

    Myocarditis Acute, Cancer Trial in Boston (Abatacept plus, Placebo)

    Recruiting
    • Myocarditis Acute
    • Cancer
    • Abatacept plus
    • Placebo
    • Los Angeles, California
    • +16 more
    Feb 1, 2023

    Tumor, Tumor, Solid, Metastasis Trial in United States (nab-sirolimus)

    Recruiting
    • Tumor
    • +20 more
    • Mobile, Alabama
    • +81 more
    Jan 24, 2023

    Cancer Trial in Los Angeles (Cardiac Aggressive Risk MitigAtion Plan)

    Recruiting
    • Cancer
    • Cardiac Aggressive Risk MitigAtion Plan
    • Los Angeles, California
      Cancer Clinical Trials Office
    Jan 10, 2023

    Cancer Trial in United States (SRK-181, anti-PD-(L)1 antibody therapy)

    Recruiting
    • Cancer
    • SRK-181
    • anti-PD-(L)1 antibody therapy
    • Fullerton, California
    • +13 more
    Jan 6, 2023

    Cancer Trial in United States (GIFT)

    Recruiting
    • Cancer
    • GIFT
    • Los Angeles, California
    • +3 more
    Jan 3, 2023

    Cancer, Tumor, Solid, Nonsmall Cell Lung Cancer Trial in United States (HMBD-002, Pembrolizumab)

    Recruiting
    • Cancer
    • +6 more
    • Duarte, California
    • +6 more
    Dec 26, 2022

    Cancer, Cancer Metastatic, Tumors Trial in Los Angeles (Virtual group based physical activity (BurnAlong) and Social Media

    Recruiting
    • Cancer
    • +21 more
    • Virtual group based physical activity (BurnAlong) and Social Media Discussion Board
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Dec 7, 2022

    Cancer, Quality of Life, Anxiety Trial in United States (Promoting Resilience in Stress Management (PRISM))

    Recruiting
    • Cancer
    • +6 more
    • Promoting Resilience in Stress Management (PRISM)
    • Los Angeles, California
    • +4 more
    Nov 29, 2022

    Solid Tumors, Cancer Trial in Worldwide (MEDI1191, Durvalumab)

    Active, not recruiting
    • Solid Tumors
    • Cancer
    • MEDI1191
    • Durvalumab
    • La Jolla, California
    • +13 more
    Nov 30, 2022

    Cancer, Bone Marrow Tumors, Anxiety Trial in United States (PRISM (Promoting Resilience in Stress Management))

    Active, not recruiting
    • Cancer
    • +7 more
    • PRISM (Promoting Resilience in Stress Management)
    • Birmingham, Alabama
    • +4 more
    Nov 29, 2022

    NSCLC, Anemia, Cancer Trial in Worldwide (Darbepoetin alfa, Placebo)

    Terminated
    Has Results
    • Non-Small Cell Lung Cancer
    • +3 more
    • Darbepoetin alfa
    • Placebo
    • Anniston, Alabama
    • +566 more
    Nov 4, 2022

    Survivorship, Cancer, Financial Stress Trial in United States (Providing financial navigation via active navigation, ad hoc

    Enrolling by invitation
    • Survivorship
    • +2 more
    • Providing financial navigation via active navigation, ad hoc navigation or no study-based navigation.
    • Los Angeles, California
    • +4 more
    Nov 11, 2022

    Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in United States (AMG 337)

    Completed
    • Advanced Malignancy
    • +5 more
    • AMG 337
    • Los Angeles, California
    • +7 more
    Nov 3, 2022

    Chemo-induced Peripheral Neuropathy, Cancer Trial in Los Angeles (Qi Gong)

    Terminated
    • Chemotherapy-induced Peripheral Neuropathy
    • Cancer
    • Qi Gong
    • Los Angeles, California
      Cedars Sinai Medical Center
    Sep 28, 2022

    Acute Myeloid Leukemia (AML), Cancer Trial in Worldwide (Venetoclax, Azacitidine, Best Supportive Care (BSC))

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • Cancer
    • Scottsdale, Arizona
    • +169 more
    Aug 23, 2022

    Cancer Trial in Worldwide (Talazoparib)

    Completed
    Has Results
    • Cancer
    • Alhambra, California
    • +37 more
    Jul 26, 2022

    Solid Tumor, Cancer, Carcinoma Trial in United States (Mogamulizumab + Nivolumab)

    Completed
    Has Results
    • Solid Tumor
    • +4 more
    • Mogamulizumab + Nivolumab
    • Gilbert, Arizona
    • +14 more
    Jul 27, 2022

    Cancer Trial in Worldwide (Atezolizumab)

    Recruiting
    • Cancer
    • Birmingham, Alabama
    • +178 more
    Aug 17, 2022